Chandrasekaran Ananthanarayanan
Research Subjects
Chandrasekaran Ananthanarayanan has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Kartik Patel
Department of Cardio Vascular and Thoracic Surgery, U. N. Mehta Institute of Cardiology and Research Center (affiliated to BJ medical college, Ahmedabad), Ahmedabad, Gujarat, India
4 shared publications Pratik Shah
Department of CVTS, U. N. Mehta Institute of Cardiology and Research Center, Civil Hospital Campus, Ahmedabad, Gujarat, India
3 shared publicationsAmber Malhotra
Department of Cardiovascular and Thoracic Surgery of the U. N. Mehta Institute of Cardiology and Research Center (affiliated to BJ Medical College, Ahmedabad), Gujarat, India
2 shared publicationsArchit Patel
Department of Cardiovascular and Thoracic Surgery U. N. Mehta Institute of Cardiology and Research Centre (Affiliated to BJ Medical College) Ahmedabad Gujarat India
2 shared publicationsChirag Doshi
Department of CVTS, U. N. Mehta Institute of Cardiology and Research Center, Civil Hospital Campus, Ahmedabad, Gujarat, India
2 shared publications- Himani Pandya
Department of Genetics and Plant breeding, College of Agriculture, NAU, Campus Bharuch -392012
2 shared publications
Latest Publications
- 3 April 2025
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
Complete Atrioventricular Septal Defect Repair in Patients With Down Syndrome Presenting Beyond Six Months— A Single Center Experience
Background: Complete atrioventricular septal defect (cAVSD) is the most common cardiac lesions associated with Down syndrome (DS). In DS, cAVSD repair is ideally performed before six months of age to prevent irreversible pulmonary artery hypertension (PAH). However, in developing countries, delayed repair is often unavoidable. We retrospectively analyzed the outcomes of cAVSD repair in DS patients presenting beyond six months of age. Method: Between 2015 and 2019, 60 DS patients with cAVSD who underwent biventricular repair were reviewed. During the same time period 42 DS patients under 6 months of age underwent cAVSD repair. Their laboratory parameters and echocardiographic data were analyzed. Clinical findings as well as echocardiographic results at last follow-up were recorded. Result: Median age of the cohort was eight months. There were 7/60 (11.7%) early mortalities due to right ventricular dysfunction secondary to persistent PAH (n = 4) and sepsis (n = 3). We found that right atrioventricular valve regurgitation (AVVR) grade (OR = 5.7, P = .017), postoperative serum bilirubin (OR = 4.03, P = .04), postoperative creatinine (OR = 7.06, P = .008), and right AVVR Gmax (OR = 6.08, P = .009) were independent risk factors for mortality. Mean follow-up was 1658 ± 771 days with a survival rate of 85% at 1, 5, and 10 years. Late reoperation (5.6% vs 3.7%) as well as prevalence of more than mild regurgitation was higher for the right AV valve as compared with the left AV valve (11.5% vs 1.9%). We did not find any factors associated with reoperation. All patients were clinically asymptomatic and did not have residual severe PAH. Conclusion: Complete Atrioventricular septal defect repair in late-presenting patients with DS is feasible and yields good long-term outcomes. However, close follow-up is necessary to monitor for the late development of right AVVR.
- 3 April 2025
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
Complete Atrioventricular Septal Defect Repair in Patients With Down Syndrome Presenting Beyond Six Months— A Single Center Experience
Background: Complete atrioventricular septal defect (cAVSD) is the most common cardiac lesions associated with Down syndrome (DS). In DS, cAVSD repair is ideally performed before six months of age to prevent irreversible pulmonary artery hypertension (PAH). However, in developing countries, delayed repair is often unavoidable. We retrospectively analyzed the outcomes of cAVSD repair in DS patients presenting beyond six months of age. Method: Between 2015 and 2019, 60 DS patients with cAVSD who underwent biventricular repair were reviewed. During the same time period 42 DS patients under 6 months of age underwent cAVSD repair. Their laboratory parameters and echocardiographic data were analyzed. Clinical findings as well as echocardiographic results at last follow-up were recorded. Result: Median age of the cohort was eight months. There were 7/60 (11.7%) early mortalities due to right ventricular dysfunction secondary to persistent PAH (n = 4) and sepsis (n = 3). We found that right atrioventricular valve regurgitation (AVVR) grade (OR = 5.7, P = .017), postoperative serum bilirubin (OR = 4.03, P = .04), postoperative creatinine (OR = 7.06, P = .008), and right AVVR Gmax (OR = 6.08, P = .009) were independent risk factors for mortality. Mean follow-up was 1658 ± 771 days with a survival rate of 85% at 1, 5, and 10 years. Late reoperation (5.6% vs 3.7%) as well as prevalence of more than mild regurgitation was higher for the right AV valve as compared with the left AV valve (11.5% vs 1.9%). We did not find any factors associated with reoperation. All patients were clinically asymptomatic and did not have residual severe PAH. Conclusion: Complete Atrioventricular septal defect repair in late-presenting patients with DS is feasible and yields good long-term outcomes. However, close follow-up is necessary to monitor for the late development of right AVVR.
- 25 November 2024
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 41 (5) , 596-600
Right atrial myxoma excision with pulmonary thrombectomy
Myxomas are the most common primary tumors of the heart. Myxomas that are smooth and large usually present with obstructive symptoms whereas the ones that are villous and friable embolize. Due to the risk of mechanical obstruction and embolization, they require immediate surgical intervention. We present a case of a young female with multiple right atrial (RA) myxomas and embolic occlusion of the right pulmonary artery (RPA) managed successfully with surgical excision and pulmonary thrombectomy.
- 25 November 2024
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 41 (5) , 596-600
Right atrial myxoma excision with pulmonary thrombectomy
Myxomas are the most common primary tumors of the heart. Myxomas that are smooth and large usually present with obstructive symptoms whereas the ones that are villous and friable embolize. Due to the risk of mechanical obstruction and embolization, they require immediate surgical intervention. We present a case of a young female with multiple right atrial (RA) myxomas and embolic occlusion of the right pulmonary artery (RPA) managed successfully with surgical excision and pulmonary thrombectomy.
- Open Access
- 1 May 2024
- Published by Wolters Kluwer Health in Journal of the Practice of Cardiovascular Sciences
- Vol. 10 (2) , 96-99
Open Surgery for Pseudoaneurysm after EVAR: A Unique Surgical Challenge
Endovascular repair of abdominal aneurysm (EVAR) has become the main stay of treatment for abdominal aortic aneurysm. Long-term follow-up studies have shown a variety of complications following EVAR, few of which are dangerous with high morbidity and mortality. Open surgery for complications of EVAR poses unique challenges to the surgeon. We present one of the serious complications following EVAR which was successfully managed by open surgery.
- 1 May 2024
- Published by Wolters Kluwer Health in Journal of the Practice of Cardiovascular Sciences
- Vol. 10 (2) , 96-99
Open AccessOpen Surgery for Pseudoaneurysm after EVAR: A Unique Surgical Challenge
Endovascular repair of abdominal aneurysm (EVAR) has become the main stay of treatment for abdominal aortic aneurysm. Long-term follow-up studies have shown a variety of complications following EVAR, few of which are dangerous with high morbidity and mortality. Open surgery for complications of EVAR poses unique challenges to the surgeon. We present one of the serious complications following EVAR which was successfully managed by open surgery.
- 23 July 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (10) , 3867-3868
Acute type A dissection, coarctation of aorta, and levoatriocardinal vein—A rare combination
Concomitant presence of acute type A dissection, coarctation of aorta and levoatriocardinal vein has not been described. We here present a case of aortic anuerysm complicated by type A dissection with coarctation of aorta and levoatriocardinal vein.
- 23 July 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (10) , 3867-3868
Acute type A dissection, coarctation of aorta, and levoatriocardinal vein—A rare combination
Concomitant presence of acute type A dissection, coarctation of aorta and levoatriocardinal vein has not been described. We here present a case of aortic anuerysm complicated by type A dissection with coarctation of aorta and levoatriocardinal vein.
- 27 January 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (3) , 1000-1009
Midterm outcome of off‐pump CABG for severe LV dysfunction—Does LV size and function predict their midterm outcome?
Background The superiority of surgical revascularization in ischemic cardiomyopathy is established beyond doubt, and off‐pump CABG (OP‐CABG) is a safe way of revascularization in this high‐risk subset. Data on the effect of postoperative ventricular function and size on their midterm outcome is scarce. Materials and Methods A retrospective study was done on 211 consecutive patients with severe LV dysfunction who underwent OP‐CABG from January 2017 to December 2018. Data were collected from the institutional database. Their operative and midterm outcomes were statistically analyzed. Results The mean age of the cohort was 58.4 ± 8.3 years. An average number of grafts was 3.1 ± 0.8 (cumulative intended number of grafts—3). Operative mortality was 10.9%. Preoperative NYHA class (p < .0001; OR, 19.72) and postoperative IABP insertion (p < .008; OR, 88.75) were independent predictors of operative mortality. The mean follow‐up period was 3.14 ± 0.07 years, was 97.4% complete with cardiac mortality of 5.8%. Postoperative LVEF (p = .002; OR, 0.868) and LV dimensions (systole & diastole) (p = .013, OR = 1.182 and p = .036, OR = 1.184, respectively) were independent predictors of midterm mortality. Midterm major adverse cardiovascular event‐free survival of operative survivors was 89%. There was no correlation between postoperative LV dimension and NYHA status(p > .05). Myocardial viability was not associated with early (p = .17) or midterm mortality (p = .676). Conclusion OP‐CABG can achieve complete revascularization in patients with severe LV dysfunction with good midterm outcomes, albeit with high early operative mortality. Postoperative change in LV dimension and EF are predictors of midterm mortality.
- 27 January 2021
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 36 (3) , 1000-1009
Midterm outcome of off‐pump CABG for severe LV dysfunction—Does LV size and function predict their midterm outcome?
Background The superiority of surgical revascularization in ischemic cardiomyopathy is established beyond doubt, and off‐pump CABG (OP‐CABG) is a safe way of revascularization in this high‐risk subset. Data on the effect of postoperative ventricular function and size on their midterm outcome is scarce. Materials and Methods A retrospective study was done on 211 consecutive patients with severe LV dysfunction who underwent OP‐CABG from January 2017 to December 2018. Data were collected from the institutional database. Their operative and midterm outcomes were statistically analyzed. Results The mean age of the cohort was 58.4 ± 8.3 years. An average number of grafts was 3.1 ± 0.8 (cumulative intended number of grafts—3). Operative mortality was 10.9%. Preoperative NYHA class (p < .0001; OR, 19.72) and postoperative IABP insertion (p < .008; OR, 88.75) were independent predictors of operative mortality. The mean follow‐up period was 3.14 ± 0.07 years, was 97.4% complete with cardiac mortality of 5.8%. Postoperative LVEF (p = .002; OR, 0.868) and LV dimensions (systole & diastole) (p = .013, OR = 1.182 and p = .036, OR = 1.184, respectively) were independent predictors of midterm mortality. Midterm major adverse cardiovascular event‐free survival of operative survivors was 89%. There was no correlation between postoperative LV dimension and NYHA status(p > .05). Myocardial viability was not associated with early (p = .17) or midterm mortality (p = .676). Conclusion OP‐CABG can achieve complete revascularization in patients with severe LV dysfunction with good midterm outcomes, albeit with high early operative mortality. Postoperative change in LV dimension and EF are predictors of midterm mortality.
- Open Access
- 6 June 2020
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 36 (4) , 423-425
Acute cardio-embolic stroke in a preschooler—a surgical dilemma
Myxomas are the most common primary intra-cardiac tumors in adults. Myxoma occurring in a preschooler is very rare, and cardiac surgery in acute stroke is a challenging decision. We present a rare case of acute cardio-embolic stroke in a 3-year-old child due to left atrial myxoma which was successfully treated.
- 6 June 2020
- Published by Springer Nature in Indian Journal of Thoracic and Cardiovascular Surgery
- Vol. 36 (4) , 423-425
Open AccessAcute cardio-embolic stroke in a preschooler—a surgical dilemma
Myxomas are the most common primary intra-cardiac tumors in adults. Myxoma occurring in a preschooler is very rare, and cardiac surgery in acute stroke is a challenging decision. We present a rare case of acute cardio-embolic stroke in a 3-year-old child due to left atrial myxoma which was successfully treated.
- Open Access
- 1 June 2019
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 107 (6) , e389-e391
Damus-Kaye-Stansel: Valuable Option for Retraining of Left Ventricle in Late Arterial Switch for Transposition of the Great Arteries
- 1 June 2019
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 107 (6) , e389-e391
Open AccessDamus-Kaye-Stansel: Valuable Option for Retraining of Left Ventricle in Late Arterial Switch for Transposition of the Great Arteries
- Open Access
- 1 January 2018
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 33 (1) , 15-22
OPCABG for Moderate CIMR in Elderly Patients: a Superior Option?
Objective: To compare the early and late outcomes of off-pump coronary artery bypass grafting and coronary artery bypass graft + mitral valve repair in elderly patients with moderate chronic ischemic mitral regurgitation. Methods: One hundred and fifty elderly (age > 70 years) patients with moderate chronic ischemic mitral regurgitation who underwent off-pump coronary artery bypass grafting (n=95) or coronary artery bypass graft + mitral valve repair (n=55) between January 2007 and December 2014 were studied. They were subdivided according to presence or absence of high operative risk. Peri-operative variables and early operative outcomes were retrospectively studied. Survival, mitral regurgitation grade, and functional outcomes were prospectively analysed. Results: Both groups were comparable in terms of age (P=0.23), sex (P=0.74), left ventricle ejection fraction (P=0.6) and preoperative functional class (P=0.52). The mean number of grafts for off-pump coronary artery bypass grafting group was 3.14 and coronary artery bypass graft + mitral valve repair was 3.21. Off-pump coronary artery bypass grafting group had statistically significant better early operative outcomes i.e perioperative blood transfusions, intra-aortic balloon pump usage, arrhythmias, renal dysfunction, liver dysfunction, sepsis, mean hours of ventilation, intensive care unit stay and operative mortality. On a prospective follow up of 5 +/- 2.33 years (1-9 years), coronary artery bypass graft + mitral valve repair in low operative risk subgroup had better improvements in mitral regurgitation grade than off-pump coronary artery bypass grafting. Both groups had similar improvements in functional class and cumulative survival was also comparable (63.2% vs. 54.5%). Conclusion: Off-pump coronary artery bypass grafting is a safer alternative to coronary artery bypass graft + mitral valve repair with better early operative outcomes and comparable late survival and functional outcomes in elderly patients with moderate chronic ischemic mitral regurgitation, especially those with higher operative risk.
- 1 January 2018
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 33 (1) , 15-22
Open AccessOPCABG for Moderate CIMR in Elderly Patients: a Superior Option?
Objective: To compare the early and late outcomes of off-pump coronary artery bypass grafting and coronary artery bypass graft + mitral valve repair in elderly patients with moderate chronic ischemic mitral regurgitation. Methods: One hundred and fifty elderly (age > 70 years) patients with moderate chronic ischemic mitral regurgitation who underwent off-pump coronary artery bypass grafting (n=95) or coronary artery bypass graft + mitral valve repair (n=55) between January 2007 and December 2014 were studied. They were subdivided according to presence or absence of high operative risk. Peri-operative variables and early operative outcomes were retrospectively studied. Survival, mitral regurgitation grade, and functional outcomes were prospectively analysed. Results: Both groups were comparable in terms of age (P=0.23), sex (P=0.74), left ventricle ejection fraction (P=0.6) and preoperative functional class (P=0.52). The mean number of grafts for off-pump coronary artery bypass grafting group was 3.14 and coronary artery bypass graft + mitral valve repair was 3.21. Off-pump coronary artery bypass grafting group had statistically significant better early operative outcomes i.e perioperative blood transfusions, intra-aortic balloon pump usage, arrhythmias, renal dysfunction, liver dysfunction, sepsis, mean hours of ventilation, intensive care unit stay and operative mortality. On a prospective follow up of 5 +/- 2.33 years (1-9 years), coronary artery bypass graft + mitral valve repair in low operative risk subgroup had better improvements in mitral regurgitation grade than off-pump coronary artery bypass grafting. Both groups had similar improvements in functional class and cumulative survival was also comparable (63.2% vs. 54.5%). Conclusion: Off-pump coronary artery bypass grafting is a safer alternative to coronary artery bypass graft + mitral valve repair with better early operative outcomes and comparable late survival and functional outcomes in elderly patients with moderate chronic ischemic mitral regurgitation, especially those with higher operative risk.
- 11 July 2016
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 24 (8) , 796-797
Dumb-bell in the heart: rare case of biatrial myxoma with mitral regurgitation
Cardiac myxomas are rare intracardiac tumors, and the majority are benign myxomas involving the left atrium. We report a case of the very rare occurrence of biatrial myxoma associated with mitral regurgitation, which was successfully treated.
- 11 July 2016
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 24 (8) , 796-797
Dumb-bell in the heart: rare case of biatrial myxoma with mitral regurgitation
Cardiac myxomas are rare intracardiac tumors, and the majority are benign myxomas involving the left atrium. We report a case of the very rare occurrence of biatrial myxoma associated with mitral regurgitation, which was successfully treated.
- 23 September 2015
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 23 (9) , 1039-1043
Hyperbilirubinemia after cardiac surgery: An observational study
Background: We aimed to assess the incidence and perioperative risk factors for hyperbilirubinemia after cardiac surgery, and determine its influence on early operative outcome. Methods: This prospective observational study was conducted on 476 patients who underwent cardiac surgical procedures from January 2014 to March 2014. Postoperative hyperbilirubinemia was defined as serum total bilirubin >2.0 mg dL −1 . Results: The overall incidence of postoperative hyperbilirubinemia was 25% (119 patients). Patients undergoing valve repair or replacement had the highest incidence of hyperbilirubinemia (36.2%), followed by coronary artery bypass grafting with concomitant valve surgery (34.1%), congenital heart surgery (23.1%), and coronary artery bypass alone (12.7%). Postoperative hyperbilirubinemia was associated with increased duration of inotropic support ( p = 0.0001), mechanical ventilation ( p = 0.0001), intensive care unit stay ( p = 0.001), hospital stay ( p = 0.006), and mortality ( p = 0.014). The perioperative factors associated with postoperative hyperbilirubinemia were increased preoperative bilirubin level ( p < 0.0001), preoperative prothrombin time ( p < 0.0001), cardiopulmonary bypass time ( p = 0.028), aortic crossclamp time ( p = 0.004), and blood transfusion units ( p = 0.0001). Conclusions: Postoperative hyperbilirubinemia is common in patients undergoing cardiopulmonary bypass and is associated with high hospital mortality. The factors associated with its occurrence are increased preoperative bilirubin level, preoperative prothrombin time, cardiopulmonary bypass time, aortic crossclamp time, and blood transfusion units. Persistent hyperbilirubinemia is associated with a worse outcome than early transient hyperbilirubinemia.
- 23 September 2015
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 23 (9) , 1039-1043
Hyperbilirubinemia after cardiac surgery: An observational study
Background: We aimed to assess the incidence and perioperative risk factors for hyperbilirubinemia after cardiac surgery, and determine its influence on early operative outcome. Methods: This prospective observational study was conducted on 476 patients who underwent cardiac surgical procedures from January 2014 to March 2014. Postoperative hyperbilirubinemia was defined as serum total bilirubin >2.0 mg dL −1 . Results: The overall incidence of postoperative hyperbilirubinemia was 25% (119 patients). Patients undergoing valve repair or replacement had the highest incidence of hyperbilirubinemia (36.2%), followed by coronary artery bypass grafting with concomitant valve surgery (34.1%), congenital heart surgery (23.1%), and coronary artery bypass alone (12.7%). Postoperative hyperbilirubinemia was associated with increased duration of inotropic support ( p = 0.0001), mechanical ventilation ( p = 0.0001), intensive care unit stay ( p = 0.001), hospital stay ( p = 0.006), and mortality ( p = 0.014). The perioperative factors associated with postoperative hyperbilirubinemia were increased preoperative bilirubin level ( p < 0.0001), preoperative prothrombin time ( p < 0.0001), cardiopulmonary bypass time ( p = 0.028), aortic crossclamp time ( p = 0.004), and blood transfusion units ( p = 0.0001). Conclusions: Postoperative hyperbilirubinemia is common in patients undergoing cardiopulmonary bypass and is associated with high hospital mortality. The factors associated with its occurrence are increased preoperative bilirubin level, preoperative prothrombin time, cardiopulmonary bypass time, aortic crossclamp time, and blood transfusion units. Persistent hyperbilirubinemia is associated with a worse outcome than early transient hyperbilirubinemia.